116 related articles for article (PubMed ID: 38195318)
1. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas.
Chen CH; Hsu NT; Chen IC; Chang TS; Cheng S; Cheng SY; Chen HM; Harn MR; Liu CK; Yang MT; Lu SL; Tseng CM; Lu SN
J Formos Med Assoc; 2024 May; 123(5):613-619. PubMed ID: 38195318
[TBL] [Abstract][Full Text] [Related]
2. Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
Chang TS; Chang KC; Chen WM; Hsu NT; Lee CY; Lin YC; Huang WC; Chiu WN; Hu JH; Huang TJ; Chen MY; Lu SN
BMJ Open; 2021 Jul; 11(7):e046115. PubMed ID: 34233977
[TBL] [Abstract][Full Text] [Related]
3. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
[TBL] [Abstract][Full Text] [Related]
4. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
5. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
[TBL] [Abstract][Full Text] [Related]
6. Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: a method to identify areas endemic for HCV.
Lu SN; Wang JH; Kuo YK; Kuo HL; Chen TM; Tung HD; Lee CM; Chen SC
Am J Trop Med Hyg; 2002 Aug; 67(2):145-50. PubMed ID: 12389938
[TBL] [Abstract][Full Text] [Related]
7. [Sero-prevalence and associated risk factors on hepatitis C in Maqiao township, Henan province of China].
Guo YH; Fan JX; Wang Z; Sun DY; Wang HF; Li ML; Liu J; Cui WG; Liu GH; Guo WS
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):722-5. PubMed ID: 22968024
[TBL] [Abstract][Full Text] [Related]
8. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
9. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
Kee KM; Chen WM; Hsu NT; Wang JH; Chao WH; Lin YC; Lu SN
J Formos Med Assoc; 2022 Sep; 121(9):1850-1856. PubMed ID: 35339312
[TBL] [Abstract][Full Text] [Related]
10. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
Kileng H; Gutteberg T; Goll R; Paulssen EJ
BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
[TBL] [Abstract][Full Text] [Related]
11. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.
Chen CH; Yang PM; Huang GT; Lee HS; Sung JL; Sheu JC
J Formos Med Assoc; 2007 Feb; 106(2):148-55. PubMed ID: 17339159
[TBL] [Abstract][Full Text] [Related]
12. Mass screening for hepatitis B and C in Southern Upper Egypt.
Soliman G; Elzalabany MS; Hassanein T; Miller FD
BMC Public Health; 2019 Oct; 19(1):1326. PubMed ID: 31640639
[TBL] [Abstract][Full Text] [Related]
13. [Anti-hepatitis C virus screening to prevent hepatitis C virus infection in blood donors].
Sun Y; Zhao Y; Liu X
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):696-9. PubMed ID: 8731835
[TBL] [Abstract][Full Text] [Related]
14. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
Torres HA; Lok AS; Suarez-Almazor ME; Warneke CL; Kaseb A; Miller E; Sturgis EM; Foreman JT; Angelidakis G; Ahmed S; Ferrajoli A; Samaniego F; Hawk ET; Hwang JP
Support Care Cancer; 2021 Jan; 29(1):97-105. PubMed ID: 32314052
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital].
He N; Hao S; Feng G; Gao J; Kong FJ; Ren ZX; Xu MQ; Yang YQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1053-1058. PubMed ID: 34933422
[No Abstract] [Full Text] [Related]
16. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C screening in hospitals: find the missing patients.
Liu L; Xu H; Hu Y; Shang J; Jiang J; Yu L; Zhao C; Zhang D; Zhang X; Li J; Li W; Wu Y; Hu D; Wang X; Zhao Q; Zhang Q; Luo W; Chen J; Zhang D; Zhou W; Niu J
Virol J; 2019 Apr; 16(1):47. PubMed ID: 30992019
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan.
Wang JH; Chen CH; Chang CM; Feng WC; Lee CY; Lu SN
J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):504-508. PubMed ID: 31350109
[TBL] [Abstract][Full Text] [Related]
20. Incident hepatitis C virus infection in a community-based population in Japan.
Okayama A; Stuver SO; Tabor E; Tachibana N; Kohara M; Mueller NE; Tsubouchi H
J Viral Hepat; 2002 Jan; 9(1):43-51. PubMed ID: 11851902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
